Stocks & Investing
Thu, June 6, 2024
[ 12:00 AM ] - WOPRAI
Fri, July 21, 2023
[ 12:00 AM ] - WOPRAI
Tue, April 4, 2023
[ 12:00 AM ] - WOPRAI
Tue, June 1, 2021
[ 12:00 AM ] - WOPRAI
Thu, May 27, 2021
[ 12:00 AM ] - WOPRAI
Mon, May 17, 2021
[ 12:00 AM ] - WOPRAI
Fri, March 12, 2021
[ 12:00 AM ] - WOPRAI
Thu, March 11, 2021
[ 12:00 AM ] - WOPRAI
Mon, March 1, 2021
[ 12:00 AM ] - WOPRAI
Wed, February 3, 2021
[ 12:00 AM ] - WOPRAI
Mon, December 28, 2020
[ 12:00 AM ] - WOPRAI
Fri, November 13, 2020
[ 12:00 AM ] - WOPRAI
Thu, August 20, 2020
[ 12:00 AM ] - WOPRAI
Mon, October 28, 2019
[ 12:00 AM ] - WOPRAI
Mon, July 15, 2019
[ 12:00 AM ] - WOPRAI
Fri, May 31, 2019
[ 12:00 AM ] - WOPRAI
Fri, April 5, 2019
[ 12:00 AM ] - WOPRAI
Tue, October 23, 2018
[ 12:00 AM ] - WOPRAI
Tue, August 7, 2018
[ 12:00 AM ] - WOPRAI
Tue, July 31, 2018
[ 12:00 AM ] - WOPRAI
Fri, May 25, 2018
[ 12:00 AM ] - WOPRAI
Wed, May 16, 2018
[ 12:00 AM ] - WOPRAI
Thu, June 18, 2015
[ 12:00 AM ] - WOPRAI
Thu, September 5, 2013
[ 12:00 AM ] - WOPRAI
Tue, February 12, 2013
[ 12:00 AM ] - WOPRAI
Mon, November 5, 2012
[ 12:00 AM ] - WOPRAI
Mon, March 26, 2012 Michelle Gilson Maintained (VIR) at Hold with Increased Target to $15 on, Jun 6th, 2024
Michelle Gilson of Morgan Stanley, Maintained "Vir Biotechnology, Inc." (VIR) at Hold with Increased Target from $12 to $15 on, Jun 6th, 2024.
Michelle has made no other calls on VIR in the last 4 months.
There are 3 other peers that have a rating on VIR. Out of the 3 peers that are also analyzing VIR, 1 agrees with Michelle's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Eric Joseph of "JP Morgan" Maintained at Hold with Increased Target to $12 on, Friday, May 3rd, 2024
These are the ratings of the 2 analyists that currently disagree with Michelle
- Joseph Stringer of "Needham" Maintained at Strong Buy with Increased Target to $19 on, Wednesday, June 5th, 2024
- Patrick Trucchio of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $110 on, Wednesday, June 5th, 2024
